ArticleEJHaem2026
Donor Blood Management: A Complementary Framework to Patient Blood Management.
Article in EJHaem, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Blood donation is a generous act that saves lives. However, the journey of the donated blood from collection to patient benefit is complex, and donor value may be reduced or lost through collection and processing losses, inventory wastage, expiry, handling errors, inappropriate clinical utilisation and incidents. Patient Blood Management (PBM) has transformed transfusion practice by promoting evidence-based blood use, yet no equivalent donor-centred framework exists to protect donor value across the full donation-to-transfusion pathway. We propose Donor Blood Management (DBM), built on four interconnected pillars: (i) Collection and processing optimisation, (ii) inventory optimisation, (iii) appropriate utilisation and (iv) haemovigilance and improvement. DBM promotes shared accountability among blood services, hospitals, clinicians and regulators to reduce avoidable losses and maximise the benefit of every donation. We also propose Donor-to-Recipient Value Yield (DRVY) as a stewardship metric to measure the proportion of donated blood ultimately transfused appropriately. DRVY is not intended to replace existing vein-to-vein data infrastructure but to provide a standardised, quality-improvement interpretation of linked donor, component and recipient data, complementing PBM within a donor-centred framework.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.